The Journal of Immunology · 1999 · 195 citations · 43 references
Life SciencesBiochemistryMolecular BiologyInnate ImmunityProtein BiochemistryProtein-protein InteractionsComplement RegulationComplement SystemComplement-mediated InjuryProtein Interaction DomainsProtein-protein RecognitionAcute-phase MediatorsAcute-phase ProteinsC-terminal Domain StructureComplement Activation ModulationComplement ComponentsComplement In Host DefenseComplement Protein Structure - Function RelationshipsComplement System Regulation
C‑reactive protein is a major acute‑phase protein with poorly understood functions. The study investigates CRP’s interaction with factor H and proposes that CRP targets active FH and FHL‑1 to injured tissues. Surface plasmon resonance with recombinant FH constructs showed CRP binds to SCR domains 7 and 8–11 of factor H. CRP binds calcium‑dependent, heparin‑inhibited to FH SCR 7–11 and FHL‑1 SCR 7, preserves FH’s C3b‑cleavage activity, and may limit tissue complement attack while permitting enhanced AP activity against microbes.
Abstract C-reactive protein (CRP) is a major acute phase protein whose functions are not totally clear. In this study, we examined the interaction of CRP with factor H (FH), a key regulator of the alternative pathway (AP) of complement. Using the surface plasmon resonance technique and a panel of recombinantly expressed FH constructs, we observed that CRP binds to two closely located regions on short consensus repeat (SCR) domains 7 and 8–11 of FH. Also FH-like protein 1 (FHL-1), an alternatively spliced product of the FH gene, bound to CRP with its most C-terminal domain (SCR 7). The binding reactions were calcium-dependent and partially inhibited by heparin. In accordance with the finding that CRP binding sites on FH were distinct from the C3b binding sites, CRP preserved the ability of FH to promote factor I-mediated cleavage of C3b. We propose that the function of CRP is to target functionally active FH and FHL-1 to injured self tissues. Thereby, CRP could restrict excessive complement attack in tissues while allowing a temporarily enhanced AP activity against invading microbes in blood.
43
Complement-dependent Clearance of Apoptotic Cells by Human Macrophages
Dror Mevorach, John Mascarenhas, Debra Gershov et al. · The Journal of Experimental Medicine · 1998 · 692 citations · Full text
Michael K. Pangburn, Robert D. Schreiber, Hans J. Müller‐Eberhard · The Journal of Experimental Medicine · 1977 · 684 citations · Full text